跳至主要内容
临床试验/NCT01022775
NCT01022775已完成3 期

Assessment of Dynamic Humeral Centering in Impingement Syndrome: a Randomized Clinical Trial

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2001年4月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
70
试验地点
1
主要终点
Constant total score as a mean and by category

研究概览

简要总结

The purpose of this study is to determine wether dynamic humeral centering is effective in patients with impingement syndrome of the shoulder

详细描述

Clinical trial with randomization for treatment and physiotherapist

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
31 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age > 30 years
  • •pain duration > 1 month
  • •presence of at least 2 positive impingement test results from Neer, Yocum and Hawkins testing
  • •total Constant score < 80.

排除标准

  • •concerning the shoulder
  • •stiffness
  • •anteroposterior instability
  • •tendinous calcification
  • •corticosteroid injection within the previous 30 days
  • •previous surgery
  • •humeral fracture
  • •inflammatory joint disease
  • •neoplastic disorders

研究组 & 干预措施

2: Nonspecific mobilisation

Active Comparator

Nonspecific mobilisation performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

干预措施: Nonspecific mobilisation (Procedure)

1: Dynamic humeral centering

Experimental

Dynamic humeral centering performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

干预措施: Dynamic humeral centering (Procedure)

结局指标

主要结局

Constant total score as a mean and by category

时间窗: at 3 months

次要结局

  • Constant total score(at 12 months)
  • Constant subscores for pain, activity, mobility and strength, and self-assessed disability on a 0- to 100-point visual analog scale, and analgesic and nonsteroidal anti-inflammatory drug (NSAID) use(at 12 months)
  • Constant subscores for pain, activity, mobility and strength, and self-assessed disability on a 0- to 100-point visual analog scale, and analgesic and nonsteroidal anti-inflammatory drug (NSAID) use(at 3 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验